Brain Diseases  >>  icosapent ethyl  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
icosapent ethyl / Generic mfg.
EVAS, NCT00839449: Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study

Completed
4
200
Japan
Eicosapentaenoic acid ethyl ester, EPADEL S900 TM (EPA ethyl ester, purity >98%)
Yamaguchi University Hospital, Nakamura Memorial Hospital, Iwate Medical University, Tohoku University, Ootemachi Hospital
Subarachnoid Hemorrhage, Cerebral Vasospasm
06/08
12/08

Download Options